The Ambivalence of Cytostatic Therapy: 52 (Recent Results in Cancer Research, 52) - Image 1

£77.26

Springer The Ambivalence of Cytostatic Therapy: 52 (Recent Results in Cancer Research, 52)

Name: The Ambivalence of Cytostatic Therapy: 52 (Recent Results in Cancer Research, 52)
Brand: Springer
Price: 77.26 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£77 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 21 days • 21 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 21 days • 1 price levels

Days at Price

Price Analysis

Most common price: £77 (21 days, 100.0%)

Price range: £77 - £77

Price levels: 1 different prices over 21 days

Description

E. GRUNDMANN The question as to whether cytostatic drugs might be carcinogenic has been presented and discussed in three experimental studies. The most extensive in vestigations were by J. H. WEISBURGER and coll. (New York, Alabama, Bethesda). They started with an exact determination of rate and localization for spon- . taneous tumors in their animal strains. Thirteen cytostatic compounds current ly in clinical use were then given in the maximally tolerated dose (MTD) to groups of 25 male and 25 female animals (rats and mice) three times weekly, in most assays over a period of 6 months. Other identical groups of animals received 0. 5 of the MTD. Each test involved 50 male and 50 female mice and the same number of rats. As positive controls, identical groups were given diethylnitrosamine, which induced tumors of liver, lungs and kidneys in the expected rates. The direct alkylating agents (Actinomycin 0, Melphalan, Mito mycin 0, Uracil mustard, Dibromomannitol and Dibromodulcitol) induced cancer in the peritoneal cavity, the site of the injections. Rats appeared to be more susceptible than mice. Other drugs (e. g. the cyclohexamide salt of phos phorodiamidic acid derivative, Natulan, DIC and streptozotocin) had a broad spectrum of carcinogenicity affecting a variety of organs. Several agents led to tumors in the hematopoietic and lymphatic systems in mice or rats or both. The correlation to the general immunosuppressive action is not quite clear. 6-Mercaptopurine induces lymphosarcomas in mice.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3642809421
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 16 January 2012
Listed Since: 12 July 2012

Barcode

No barcode data available

Springer The Ambivalence of Cytostatic Therapy: 52 (Recent Results in Cancer Research, 52)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Chemistry of Antitumour Agents

Chemotherapy for Leukemia: Novel Drugs and Treatment

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Prognostic Factors and Treatment Strategies (v. 8) (Haematology and Blood Transfusion)

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)

Advance in the Treatment of Pediatric Leukemia

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Cancer Chemotherapy: Basic Science to the Clinic

Cyclophosphamide: Clinical Pharmacology, Uses & Potential Adverse Effects

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Humana Anticancer Drug Development Guide - Cancer Drug Discovery

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Physicians' Cancer Chemotherapy Drug Manual 2015

Springer Biochemical Modulation of Anticancer Agents Book

Small Molecules in Hematology: 212 (Recent Results in Cancer Research, 212)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Pediatric Oncology Nursing: Advanced Clinical Handbook

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)